Comparison of efficacy, safety, and cost of low-molecular-weight heparin with continuous-infusion unfractionated heparin for initiation of anticoagulation after mechanical prosthetic valve implantation
Department of Quantitative Health Sciences
Anticoagulants; Case-Control Studies; Female; *Heart Valve Prosthesis Implantation; Heparin; Heparin, Low-Molecular-Weight; Hospital Costs; Humans; Infusions, Intravenous; Length of Stay; Male; Middle Aged; Safety; Warfarin
Biostatistics | Epidemiology | Health Services Research
We compared the efficacy, safety, and impact on postoperative hospital length of stay and inpatient hospital costs of low-molecular-weight heparin with that of unfractionated heparin as a "bridge" to achieving therapeutic levels of anticoagulation with warfarin in patients with newly implanted prosthetic heart valves. The patients who received low-molecular-weight heparin had a shorter length of stay and decreased postoperative costs compared with the control subjects receiving unfractionated heparin.
Rights and Permissions
Citation: Am J Cardiol. 2004 Jan 15;93(2):247-50.
The American journal of cardiology
Fanikos, John; Tsilimingras, Kanella; Kucher, Nils; Rosen, Allison B.; Hieblinger, Melissa D.; and Goldhaber, Samuel Z., "Comparison of efficacy, safety, and cost of low-molecular-weight heparin with continuous-infusion unfractionated heparin for initiation of anticoagulation after mechanical prosthetic valve implantation" (2004). Quantitative Health Sciences Publications and Presentations. 889.